HDAC6 and acute lymphoblastic leukemia: Inhibition of HDAC6 by HDIs causes acetylation and degradation of hsp90 chaperone and α-tubulin function in leukemic cells, increasing drug sensitivity of malignant cells to cytarabine (Figure 2.A).30,33 Other studies have indicated the overexpression of HDAC6 in ALL.